Board declares Interim Dividend
Suven Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 05, 2016, inter alia, has approved the following matters:1. The Board declared an interim dividend of Rs. 1/- per equity share and a onetime special dividend of Rs. 1/- per equity share totaling to Rs. 2/- per equity share of Rs. 1/- each for the year 2015-2016.2. The above said dividend will be paid on and from March 23, 2016. Fixes Record Date for Interim Dividend
Suven Life Sciences Ltd has informed BSE that the Company has fixed March 15, 2016 as the Record Date for the purpose of Payment of Interim Dividend, if considered and approved by the Board. Board to consider Interim Dividend
Suven Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 05, 2016, inter alia, to consider the following:- To consider Interim Dividend, if any, for the financial year 2015-16 and related matters etc.Further, the TRADING WINDOW for dealing in the securities of the Company is closed from March 02, 2016 to March 07, 2016 (both days inclusive). Trading window will be opened from March 08, 2016. Suven Life Gets Patent for Neuro-Degenerative Drug
The patents from Australia and Canada will be valid till 2032 and 2031, respectively, the company added. Suven Life Sciences secures two (2) Product Patents in Australia and Canada
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated February 19, 2016, titled "Suven Life Sciences secures two (2) Product Patents in Australia and Canada ". Earning Presentation
Suven Life Sciences Ltd has submitted to BSE a copy of Earning Presentation - Q3 & 9M FY 2016
Suven Life Sciences net profit falls 45% to Rs17 crore
Suven Life Sciences, which is into drug discovery, says it spent about Rs15 crore or 13% of revenue on research and development Result Presentation for December 31, 2015
Suven Life Sciences Ltd has informed BSE about : 1. Result Presentation for the period ended December 31, 2015 Financial Results, Limited Review Report, Results Press Release for December 31, 2015
Suven Life Sciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Standalone Limited Review for the period ended December 31, 20153. Result Press Release for the period ended December 31, 2015 Board Intimation for Results & Closure of Trading Window
Suven Life Sciences Ltd has informed BSE that a Board Meeting of the Company will be held on February 12, 2016, inter alia, to consider and take on record the Un-audited Financial Results for the quarter and nine months ended December 31, 2015.Further, the TRADING WINDOW for dealing in the securities of the Company is closed from February 04, 2016 to February 14, 2016 (both days inclusive). Trading window will be opened from February 15, 2016.